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Objective
•To investigate the feasibility study of haplotype-based noninvasive prenatal testing (NIPT) of Spinal Muscular Atrophy (SMA).
Conclusions
• NIPT strategy for SMA through targeted sequencing of maternal plasma DNA is accurate and the haplotype-based method should be evaluated systematically in a larger population and may serve as a robust and accurate NIPT for SMA.
Results
• Parental haplotypes across the SMN1 gene and flanking region were constructed based on the genotyping information from the mother, father and proband child (Figure 1 ). The number of informative SNPs on the 221.43-kb target region used for fetal haplotype construction in each family ranged from 95 to 1186. According to parental haplotypes and maternal plasma DNA sequencing data, the PAHP-assisted method identified two normal fetuses (Cases 1 and 5), two carriers (Cases 2 and 3) and one affected fetus (Case 4) (Table 1 and Figure S1 ). The results were consistent with the standard prenatal diagnosis method using MLPA of AF or CV samples, with no false-positive or -negative result.
• Table S1 may 
